Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 18, 2008
- Taiyo Completes Expansion of Its Production Facilities
February 18, 2008
- TOPICS／Merck Seiyaku Renamed Mylan Seiyaku
February 11, 2008
- Chugai's Sunrise 2012 Plan Calls For Sales of \460 Bil.
February 11, 2008
- Takeda Acquires Amgen in Japan
February 11, 2008
- NEW PRODUCTS／Bayer Launches EOB Primovist for MRI of the Liver
February 11, 2008
- Mediceo Paltac to Embark on Generics Business in Earnest
February 11, 2008
- BUSINESS NEWS IN BRIEF
February 11, 2008
- Shigeo Oyagi Elected President, CEO of Teijin Limited
February 11, 2008
- All ARBs, SSRIs to Be Re-priced
February 11, 2008
- Repeat Consultation Fee for Clinics Will Not Be Cut: Chuikyo
February 11, 2008
- Actemra to Be Approved for RA
February 11, 2008
- REGULATORY NEWS IN BRIEF
February 11, 2008
- Japan Should Take Part in More Multinational Clinical Trials: JMACCT Conference
February 11, 2008
- Live Vaccine Development Important for New-type Influenza
February 11, 2008
- R&D NEWS IN BRIEF
February 11, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 11, 2008
- TOPICS／Debt of Failing Med. Institutions Triples in 2007
February 4, 2008
- Stelic Develops STNM-01 to Treat Stenosis in Crohn's Disease
February 4, 2008
- Nihon Chouzai to Discontinue Bulk Buying: President Mitsuhara
February 4, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…